[TRVI] YoY Annual Result on 31-Dec-2023 [#FY]

Stock
[TRVI] Trevi Therapeutics, Inc.
Announcement Date
20-Mar-2024
Financial Year
2023
Quarter
31-Dec-2023 [#FY]
Profit Trend
YoY- 0.30%
Quarter Report
TRVI's Result
TRVI's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -29,097 -29,188 -33,961 -32,776 -26,068 -20,669 -12,886 14.53%
Tax -32 -36 -21 -18 -18 -124 -26 3.51%
NP -29,065 -29,152 -33,940 -32,758 -26,050 -20,545 -12,860 14.54%
Tax Rate - - - - - - - -
Total Cost 29,065 29,152 33,940 32,758 26,050 20,545 12,860 14.54%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -0.29 -0.45 -1.49 -1.81 -2.22 -2.29 -1.43 -23.34%
EPS Diluted -0.29 -0.45 -1.49 -1.81 -2.22 -2.29 -1.43 -23.34%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.